| Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037) | Journal of Clinical Oncology | 2018 | 176 |
| Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017 | Journal of Clinical Oncology | 2018 | 107 |
| Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | | 2018 | 105 |
| Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial | JAMA Oncology | 2018 | 101 |
| Evolutionary Pressure against MHC Class II Binding Cancer Mutations | Cell | 2018 | 98 |
| Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma | JAMA Oncology | 2018 | 72 |
| RosettaAntibodyDesign (RAbD): A general framework for computational antibody design | PLoS Computational Biology | 2018 | 53 |
| Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program | Oncologist | 2018 | 51 |
| IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (Histone 3 Lysine 14) | Arteriosclerosis, Thrombosis, and Vascular Biology | 2018 | 49 |
| Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer | Journal of Clinical Oncology | 2018 | 45 |
| Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults | JAMA Oncology | 2018 | 41 |
| Approved checkpoint inhibitors in bladder cancer: which drug should be used when? | Therapeutic Advances in Medical Oncology | 2018 | 40 |
| BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance | Cell Reports | 2018 | 39 |
| Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC) | Cancers of the Head & Neck | 2018 | 34 |
| NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018 | Journal of the National Comprehensive Cancer Network: JNCCN | 2018 | 33 |
| Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions | Current Urology Reports | 2018 | 32 |
| Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma | Cancer | 2018 | 28 |
| Surgical Management of Lung Cancer: History, Evolution, and Modern Advances | Current Oncology Reports | 2018 | 27 |
| Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results | Journal of the National Cancer Institute | 2018 | 25 |
| A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806 | American Journal of Hematology | 2018 | 25 |
| Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors | Clinical Cancer Research | 2018 | 24 |
| AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer | Head and Neck | 2018 | 24 |
| Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma | Annals of Oncology | 2018 | 22 |
| Racial Disparities in the Molecular Landscape of Cancer | Anticancer Research | 2018 | 20 |
| Early Enteral Nutrition is Associated with Faster Post-Esophagectomy Recovery in Chinese Esophageal Cancer Patients: A Retrospective Cohort Study | Nutrition and Cancer | 2018 | 19 |
